TFF Pharmaceuticals (TFFP) Competitors $0.06 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TFFP vs. REVB, PTEIQ, ENVB, EVFM, NMTR, ADTX, VIRX, BIOR, BDRX, and PRFXShould you be buying TFF Pharmaceuticals stock or one of its competitors? The main competitors of TFF Pharmaceuticals include Revelation Biosciences (REVB), PolarityTE (PTEIQ), Enveric Biosciences (ENVB), Evofem Biosciences (EVFM), 9 Meters Biopharma (NMTR), Aditxt (ADTX), Viracta Therapeutics (VIRX), Biora Therapeutics (BIOR), Biodexa Pharmaceuticals (BDRX), and PainReform (PRFX). These companies are all part of the "pharmaceutical products" industry. TFF Pharmaceuticals vs. Revelation Biosciences PolarityTE Enveric Biosciences Evofem Biosciences 9 Meters Biopharma Aditxt Viracta Therapeutics Biora Therapeutics Biodexa Pharmaceuticals PainReform Revelation Biosciences (NASDAQ:REVB) and TFF Pharmaceuticals (NASDAQ:TFFP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations. Which has more risk and volatility, REVB or TFFP? Revelation Biosciences has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500. Comparatively, TFF Pharmaceuticals has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Does the media prefer REVB or TFFP? In the previous week, Revelation Biosciences' average media sentiment score of 0.00 equaled TFF Pharmaceuticals'average media sentiment score. Company Overall Sentiment Revelation Biosciences Neutral TFF Pharmaceuticals Neutral Do analysts rate REVB or TFFP? TFF Pharmaceuticals has a consensus price target of $44.00, indicating a potential upside of 67,592.31%. Given TFF Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe TFF Pharmaceuticals is more favorable than Revelation Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revelation Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00TFF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of REVB or TFFP? 12.8% of Revelation Biosciences shares are owned by institutional investors. Comparatively, 15.3% of TFF Pharmaceuticals shares are owned by institutional investors. 0.1% of Revelation Biosciences shares are owned by insiders. Comparatively, 4.5% of TFF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community believe in REVB or TFFP? TFF Pharmaceuticals received 37 more outperform votes than Revelation Biosciences when rated by MarketBeat users. Likewise, 67.68% of users gave TFF Pharmaceuticals an outperform vote while only 63.83% of users gave Revelation Biosciences an outperform vote. CompanyUnderperformOutperformRevelation BiosciencesOutperform Votes3063.83% Underperform Votes1736.17% TFF PharmaceuticalsOutperform Votes6767.68% Underperform Votes3232.32% Is REVB or TFFP more profitable? Revelation Biosciences has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -1,596.64%. Revelation Biosciences' return on equity of -193.51% beat TFF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Revelation BiosciencesN/A -193.51% -84.00% TFF Pharmaceuticals -1,596.64%-310.17%-196.06% Which has preferable earnings and valuation, REVB or TFFP? Revelation Biosciences has higher earnings, but lower revenue than TFF Pharmaceuticals. Revelation Biosciences is trading at a lower price-to-earnings ratio than TFF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevelation BiosciencesN/AN/A-$120K-$268.16-0.02TFF Pharmaceuticals$730K0.40-$21.24M-$6.44-0.01 SummaryTFF Pharmaceuticals beats Revelation Biosciences on 11 of the 15 factors compared between the two stocks. Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TFFP vs. The Competition Export to ExcelMetricTFF PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$289,000.00$7.05B$5.84B$9.15BDividend YieldN/A2.75%4.75%3.85%P/E Ratio-0.015.9726.4919.17Price / Sales0.40268.58435.3770.93Price / CashN/A65.6738.0134.83Price / Book0.026.707.644.62Net Income-$21.24M$138.76M$3.19B$246.06M7 Day PerformanceN/A-2.63%-2.12%-2.63%1 Month PerformanceN/A-2.33%-0.45%-2.16%1 Year PerformanceN/A-5.33%16.26%12.88% TFF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TFFPTFF Pharmaceuticals1.2876 of 5 stars$0.07flat$44.00+67,592.3%N/A$289,000.00$730,000.00-0.0119High Trading VolumeREVBRevelation Biosciences0.1594 of 5 stars$4.28+2.9%N/A-91.5%$1.16MN/A-0.0210Negative NewsPTEIQPolarityTEN/A$0.15flatN/A+49.3%$1.09M$810,000.00-0.0560ENVBEnveric Biosciences0.9391 of 5 stars$1.60+0.6%N/A-89.4%$1.09MN/A-0.0420EVFMEvofem BiosciencesN/A$0.01+3.3%N/A-65.9%$1.08M$18.22M-0.02120Gap UpNMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220ADTXAditxt0.9193 of 5 stars$0.07-6.5%N/A-99.9%$996,000.00$640,000.000.0060News CoverageGap DownHigh Trading VolumeVIRXViracta Therapeutics2.8948 of 5 stars$0.02+1.2%$4.05+23,584.2%-94.7%$680,000.00N/A-0.0220BIORBiora Therapeutics1.9949 of 5 stars$0.12-22.0%$23.00+18,675.5%-98.5%$554,000.00$892,000.00-0.01120Gap DownBDRXBiodexa Pharmaceuticals0.7149 of 5 stars$4.27-11.8%N/AN/A$512,000.00$470,000.000.0020Gap DownHigh Trading VolumePRFXPainReform1.9988 of 5 stars$2.82-2.8%$8.00+183.7%-60.5%$395,000.00N/A-0.024Negative NewsGap Down Related Companies and Tools Related Companies Revelation Biosciences Competitors PolarityTE Competitors Enveric Biosciences Competitors Evofem Biosciences Competitors 9 Meters Biopharma Competitors Aditxt Competitors Viracta Therapeutics Competitors Biora Therapeutics Competitors Biodexa Pharmaceuticals Competitors PainReform Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TFFP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TFF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
